Business
Ex-Legend CEO Ying Huang Takes Over a Startup Scouring the Globe — Especially China — for Drugs
K2 Therapeutics, a Flagship-style ‘hub-and-spoke’ biotech that in-licenses drug candidates worldwide, named the former Legend Biotech chief as its new leader.